Other peripheral vertigo

H8_PERIPHVERTIGO

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — H81.3 Cause of death: ICD-10 — H81.3 2 out of 7 registries used, show all original rules.	3535
4. Check minimum number of events None	3535
5. Include endpoints None	3535
6. Filter based on genotype QC (FinnGen only)	3535

Control definitions (FinnGen only)

Control exclude: H8_INNER

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: H81
Name in latin: Alia vertigo peripherica

NAME	H8_PERIPHVERTIGO
CONTROL_EXCLUDE	H8_INNER
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	H813
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	H813
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other peripheral vertigo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	22431	14326	8009
Only index persons	21331	13746	7585
Unadjusted period prevalence (%)
Whole population	0.34	0.41	0.22
Only index persons	0.43	0.51	0.29
Median age at first event (years)
Whole population	59.92	60.67	58.74
Only index persons	59.30	59.97	58.08

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3535	2281	1254
Unadjusted period prevalence (%)	0.70	0.78	0.55
Median age at first event (years)	58.23	56.79	60.85

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3166: Matched controls
31658

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R42

ICD-10 Finland

Dizziness and giddiness

12.1

323.0

2012

3984

H81.2

ICD-10 Finland

Vestibular neuronitis

469.2

323.0

338

H81.0

ICD-10 Finland

Ménière disease

104.3

323.0

409

H81.3

ICD-10 Finland

Other peripheral vertigo

4503599627370496.0

323.0

3165

114

N07CA01

ATC

betahistine; oral

13.2

323.0

917

947

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

13.5

323.0

865

860

DFF59

NOMESCO Finland

Other assessment of balance

45.3

171.3

212

Z01.1

ICD-10 Finland

Examination of ears and hearing

3.6

140.2

732

2410

AA1AD

NOMESCO Finland

CT of head and brain

2.9

137.9

1089

4828

N17

ICPC

Vertigo/dizziness

3.7

122.4

613

1927

DFF00

NOMESCO Finland

Pure tone audiometry

4.2

121.5

522

1434

H90.4

ICD-10 Finland

Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

6.5

103.8

288

483

DFF50

NOMESCO Finland

Electronystagmography

210.3

79.6

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

2.5

76.0

707

3254

UDC00

NOMESCO Finland

Ear microscopy

3.5

66.0

340

1059

H81.4

ICD-10 Finland

Vertigo of central origin

26.3

62.3

H81.9

ICD-10 Finland

Disorder of vestibular function, unspecified

17.8

60.0

R51.80

ICD-10 Finland

Headache

2.5

60.0

544

2436

DE2CG

NOMESCO Finland

Acoustic channel extensive MRI examination with high intensity magnet

10.1

59.4

121

124

G44.2

ICD-10 Finland

Tension-type headache

2.5

57.1

507

2239

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

56.6

1179

7544

H91.2

ICD-10 Finland

Sudden idiopathic hearing loss

6.3

56.4

157

262

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

3.0

52.4

329

1175

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

50.4

950

5809

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

3.0

49.0

315

1141

A02BC02

ATC

pantoprazole; systemic

1.8

47.6

2101

16759

DC1AD

NOMESCO Finland

Temporalbone CT

11.7

47.4

R11

ICD-10 Finland

Nausea and vomiting

2.8

46.8

326

1241

DFF40

NOMESCO Finland

Otoneurologic examination of vertigo

59.8

45.4

H93.1

ICD-10 Finland

Tinnitus

2.9

40.7

262

945

A02BC05

ATC

esomeprazole; systemic

1.7

39.1

1321

9514

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

39.0

709

4210

H02AB06

ATC

prednisolone; systemic

1.6

38.6

1474

10965

M79.6

ICD-10 Finland

Pain in limb

1.7

38.4

1146

7957

M03BX02

ATC

tizanidine; oral

1.6

37.8

1893

15104

DE2BG

NOMESCO Finland

Acoustic channel MRI examination with high intensity magnet

9.0

37.7

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

37.4

1391

10243

N02BE01

ATC

paracetamol; systemic, rectal

1.9

37.2

2715

24097

H82

ICPC

Vertiginous syndrome

5.7

37.0

109

196

N05AB04

ATC

prochlorperazine; systemic, rectal

4.9

36.6

125

266

M54.5

ICD-10 Finland

Low back pain

1.7

36.1

1016

6907

H80.9

ICD-10 Finland

Otosclerosis, unspecified

124.8

34.7

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.4

34.5

304

1317

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.8

34.0

647

3877

DFF15

NOMESCO Finland

Speech audiometry

3.2

33.5

189

623

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

32.1

414

2142

R01AD09

ATC

mometasone; nasal

1.6

31.8

1334

9988

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.4

31.7

294

1307

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

31.4

692

4338

R53

ICD-10 Finland

Malaise and fatigue

1.8

30.9

647

3987

L01

ICPC

Neck symptom/complaint

2.0

30.4

459

2522

J01DB01

ATC

cefalexin; oral

1.6

30.2

2477

21707

XF400

NOMESCO Finland

ECG with 12 standard connections

1.8

29.3

541

3191

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

29.3

923

6392

N03AX16

ATC

pregabalin; oral

1.7

29.2

752

4924

R06.0

ICD-10 Finland

Dyspnoea

1.7

29.0

798

5322

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

28.9

562

3374

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

28.8

527

3101

H80.0

ICD-10 Finland

Otosclerosis involving oval window, nonobliterative

151.4

28.7

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

28.2

724

4730

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

28.1

1151

8494

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

28.0

1385

10676

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.1

27.2

330

1658

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

27.1

1466

11500

M54.2

ICD-10 Finland

Cervicalgia

2.4

26.9

239

1038

J01AA02

ATC

doxycycline; systemic

1.6

26.7

2396

21014

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.6

26.1

902

6356

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

2.1

26.1

324

1641

G47.3

ICD-10 Finland

Sleep apnoea

1.7

26.1

608

3851

R07.3

ICD-10 Finland

Other chest pain

2.1

25.9

317

1598

M79.1

ICD-10 Finland

Myalgia

1.9

25.8

408

2271

R01AD08

ATC

fluticasone; nasal

1.6

25.8

836

5794

G43.9

ICD-10 Finland

Migraine, unspecified

2.8

25.6

175

654

R55

ICD-10 Finland

Syncope and collapse

2.0

25.3

343

1803

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.7

25.2

547

3385

H53.1

ICD-10 Finland

Subjective visual disturbances

2.4

25.2

222

959

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

25.0

321

1651

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.2

24.8

267

1272

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.7

24.8

664

4369

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

24.6

681

4519

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.4

24.3

218

951

K30

ICD-10 Finland

Functional dyspepsia

2.0

24.2

345

1849

M01AB05

ATC

diclofenac; systemic, rectal

1.5

24.1

1982

16810

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

23.8

497

3037

XF404

NOMESCO Finland

Ambulatory ECG

2.0

23.7

313

1624

DDA00

NOMESCO Finland

Stapedotomy

126.0

23.6

A02BA02

ATC

ranitidine; systemic

1.7

23.5

634

4168

A02BC03

ATC

lansoprazole; oral

1.5

22.9

911

6595

N01

ICPC

Headache

2.1

22.7

278

1397

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

22.6

776

5422

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

22.6

602

3942

M01AE02

ATC

naproxen; oral, rectal

1.4

22.5

1636

13438

M01AH05

ATC

etoricoxib; oral

1.4

22.3

1720

14284

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

22.1

1148

8797

J01FA09

ATC

clarithromycin; systemic

1.5

22.1

922

6738

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.3

22.0

220

1010

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

21.9

1559

12727

SPAT1263

SPAT

Sampling

1.5

21.8

1256

9826

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.6

21.8

168

676

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.1

21.7

120

393

Z01.2

ICD-10 Finland

Dental examination

1.5

21.4

1134

8711

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.4

21.3

186

801

M25.5

ICD-10 Finland

Pain in joint

1.5

20.8

829

5985

J01FA10

ATC

azithromycin; systemic

1.4

20.5

1635

13570

H02

ICPC

Hearing complaint

1.8

20.4

386

2278

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

20.4

702

4892

UJF32

NOMESCO Finland

Coloscopy

1.5

20.3

780

5572

N06AX11

ATC

mirtazapine; oral

1.5

20.3

928

6894

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

3.2

20.2

110

356

L03

ICPC

Low back symptom/complaint

1.6

20.1

705

4931

C07AB07

ATC

bisoprolol; oral

1.4

20.1

1428

11578

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

20.0

1986

17131

UKC02

NOMESCO Finland

Cystoscopy

1.7

19.8

474

2999

H83.1

ICD-10 Finland

Labyrinthine fistula

+∞

19.8

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

19.8

460

2891

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.4

19.7

167

705

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.9

19.7

317

1771

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

19.7

400

2415

A02BC01

ATC

omeprazole; systemic

1.5

19.5

821

5983

N02AX02

ATC

tramadol; systemic, rectal

1.4

19.4

1245

9876

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

19.0

468

2985

N03AX12

ATC

gabapentin; oral

1.7

18.8

463

2951

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.0

18.7

249

1295

XF402

NOMESCO Finland

ECG with work load test

1.8

18.7

356

2102

R00.2

ICD-10 Finland

Palpitations

2.1

18.6

227

1140

SPAT1097

SPAT

Recording of ECG

1.7

18.5

471

3029

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

18.2

1118

8769

R51

ICD-10 Finland

Headache

2.4

18.1

160

692

J01MA02

ATC

ciprofloxacin; systemic

1.4

18.1

1123

8820

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

18.1

345

2036

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.8

17.9

334

1958

H90.6

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, bilateral

3.9

17.5

192

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

17.4

1313

10660

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

17.4

310

1792

H90.1

ICD-10 Finland

Conductive hearing loss, unilateral with unrestricted hearing on the contralateral side

4.9

17.3

115

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

17.2

348

2092

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

17.1

125

490

R03AC02

ATC

salbutamol; inhalant

1.4

17.0

1499

12487

C07AA05

ATC

propranolol; systemic

1.6

16.9

543

3700

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.3

16.9

155

686

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

16.7

785

5820

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.2

16.7

172

803

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.0

16.7

215

1105

H91.9

ICD-10 Finland

Hearing loss, unspecified

2.4

16.6

142

606

P01AB01

ATC

metronidazole; oral, rectal

1.4

16.5

1140

9088

J01DA01

ATC

[U] cefalexin; systemic

1.4

16.5

1822

15727

TPH04

NOMESCO Finland

Cathetrisation of vein

1.5

16.3

596

4180

R05

ICD-10 Finland

Cough

1.5

16.3

563

3898

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.6

16.3

510

3453

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

16.3

1044

8207

H04.10

ICD-10 Finland

Dry eye syndrome

1.8

16.1

294

1710

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

16.1

753

5569

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

16.1

187

922

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.5

16.1

538

3702

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

16.0

291

1691

L08

ICPC

Shoulder symptom/complaint

1.5

15.9

553

3837

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

15.9

1229

9976

H02AB04

ATC

methylprednisolone; systemic

1.6

15.8

430

2809

R12

ICD-10 Finland

Heartburn

1.9

15.6

221

1179

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

15.5

1748

15063

SPAT1104

SPAT

Monitoring of emergency patient

2.0

15.5

212

1117

SPAT1043

SPAT

Audiometry

1.7

15.1

322

1965

SPAT1312

SPAT

General health counselling

1.4

15.1

889

6861

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.3

15.1

137

601

SPAT1153

SPAT

Removal of sutures

1.4

15.1

927

7211

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.1

15.1

268

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

15.0

140

626

R06AE07

ATC

cetirizine; oral

1.4

14.9

1209

9856

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

3.5

14.9

205

J01CA04

ATC

amoxicillin; systemic

1.4

14.9

2326

21077

K02.1

ICD-10 Finland

Caries of dentine

1.3

14.8

1501

12676

R02

ICPC

Shortness of breath/dyspnoea

1.7

14.8

354

2229

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

14.7

1730

14953

H80.1

ICD-10 Finland

Otosclerosis involving oval window, obliterative

+∞

14.6

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

14.5

170

839

J02AC01

ATC

fluconazole; systemic

1.4

14.3

1131

9165

A04

ICPC

Weakness/tiredness general

1.6

14.2

362

2322

WX290

NOMESCO Finland

Other blockade of nerve

1.4

14.2

1089

8783

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

14.2

332

2081

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.1

14.2

157

760

L17

ICPC

Foot/toe symptom/complaint

1.4

14.0

725

5449

D82

ICPC

Teeth/gum disease

1.4

14.0

886

6909

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

14.0

874

6803

WX110

NOMESCO Finland

Local anesthesy

1.3

13.9

1915

16887

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

13.9

220

1221

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

13.8

396

2615

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

13.8

756

5743

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.8

13.8

264

1560

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.9

13.7

208

1138

M02AA07

ATC

piroxicam; topical

1.4

13.6

1074

8680

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.6

13.6

383

2517

DFE00

NOMESCO Finland

Insertion of cochlear implant

14.8

13.6

A11

ICPC

Chest pain NOS

1.8

13.5

232

1322

DE2CF

NOMESCO Finland

Acoustic channel extensive MRI examination with median intensity magnet

140.6

13.5

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.5

13.3

100

401

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

13.3

1078

8744

L15

ICPC

Knee symptom/complaint

1.5

13.3

596

4352

N05BA04

ATC

oxazepam; oral

1.4

13.2

681

5106

J01FA06

ATC

roxithromycin; oral

1.3

13.2

1159

9518

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

13.1

648

4823

L12

ICPC

Hand/finger symptom/complaint

1.6

13.0

386

2570

X59

ICD-10 Finland

Exposure to unspecified factor

1.5

13.0

479

3355

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

12.9

179

946

H81.8

ICD-10 Finland

Other disorders of vestibular function

22.6

12.9

D11

ICPC

Diarrhoea

1.7

12.8

279

1712

SPAT1310

SPAT

Counselling related to known health issue

1.4

12.8

893

7058

R21

ICPC

Throat symptom/complaint

1.5

12.7

457

3182

R06AE53

ATC

cyclizine, combinations; systemic

5.0

12.7

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

12.6

1512

12972

R05

ICPC

Cough

1.4

12.6

613

4541

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

2.6

12.6

349

38699

ICD-8 Finland

+∞

12.5

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

12.5

300

1894

UJF30

NOMESCO Finland

Ileoscopy through colon

1.7

12.5

261

1585

N06AX21

ATC

duloxetine; oral

1.7

12.4

289

1807

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.5

12.3

506

3625

S18

ICPC

Laceration/cut

1.3

12.3

1184

9826

C01CA24

ATC

epinephrine; parenteral

2.0

12.3

158

812

J20

ICD-10 Finland

Acute bronchitis

1.7

12.3

267

1636

H92.0

ICD-10 Finland

Otalgia

2.1

12.2

142

702

M01AX17

ATC

nimesulide; oral

1.4

12.2

714

5474

N06AA09

ATC

amitriptyline; systemic

1.6

12.2

304

1936

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

12.1

477

3383

R01AD12

ATC

fluticasone furoate; nasal

1.4

12.1

750

5798

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

12.1

227

1333

L13

ICPC

Hip symptom/complaint

1.5

12.1

467

3303

S06.0

ICD-10 Finland

Concussion

1.7

12.0

268

1657

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

12.0

119

547

N06AB04

ATC

citalopram; systemic

1.4

12.0

582

4305

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

12.0

364

2435

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

11.9

291

1842

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

11.9

969

7830

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

11.9

1179

9810

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

3.5

11.9

156

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

11.8

126

600

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.1

11.8

128

613

R74

ICPC

Upper respiratory infection acute

1.4

11.7

678

5176

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

11.6

274

1719

L02

ICPC

Back symptom/complaint

1.7

11.6

241

1458

DFX00

NOMESCO Finland

Connecting cochlear implant

19.0

11.6

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.1

11.6

122

580

R00.0

ICD-10 Finland

Tachycardia, unspecified

2.2

11.4

115

532

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.4

11.4

685

5259

R00.1

ICD-10 Finland

Bradycardia, unspecified

2.4

11.4

416

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

11.3

698

5385

J02AC02

ATC

itraconazole; systemic

1.5

11.3

489

3537

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.3

11.3

101

444

R52.9

ICD-10 Finland

Pain, unspecified

1.7

11.2

234

1418

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

2.8

11.2

252

DAX08

NOMESCO Finland

Fitting of hearing aid

2.1

11.2

131

651

R03BA08

ATC

ciclesonide; inhalant

1.7

11.1

228

1374

SPAT1254

SPAT

Administration of medicine

1.5

11.1

394

2733

C10AA05

ATC

atorvastatin; oral

1.3

11.1

1083

8974

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

11.1

268

1691

C03EA02

ATC

trichlormethiazide and potassium-sparing agents; oral

2.8

11.0

249

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

11.0

309

2030

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.1

11.0

194

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

10.9

218

1305

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

10.9

1173

9841

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.4

10.7

385

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.9

10.7

154

827

H81

ICD-10 Finland

Disorders of vestibular function

12.9

10.6

M54.3

ICD-10 Finland

Sciatica

1.9

10.6

165

912

ACC51

NOMESCO Finland

Release of median nerve

1.7

10.6

201

1183

A02BC04

ATC

rabeprazole; oral

1.7

10.6

230

1412

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.0

10.5

125

624

D06

ICPC

Abdominal pain localized other

1.7

10.5

215

1296

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.7

10.5

220

1336

M02AA10

ATC

ketoprofen; topical

1.4

10.4

447

3224

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

10.4

813

6505

M79.7

ICD-10 Finland

Fibromyalgia

2.3

10.4

431

H02AB07

ATC

prednisone; oral

1.5

10.3

396

2790

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

10.3

667

5181

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.2

10.2

452

Z71.9

ICD-10 Finland

Counselling, unspecified

1.9

10.2

154

844

C05AA08

ATC

fluocortolone; rectal, topical

1.5

10.1

389

2743

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

10.1

1388

11995

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.5

10.1

412

2941

SPAT1216

SPAT

Assessment of functional ability

1.5

10.1

423

3038

C09CA06

ATC

candesartan; oral

1.4

10.1

582

4430

R05FB02

ATC

cough suppressants and expectorants

1.3

10.1

1072

8960

XKD00

NOMESCO Finland

Uroflowmetry

1.5

10.1

386

2722

N05CF01

ATC

zopiclone; oral

1.3

10.0

893

7281

Z3229

NOMESCO Finland

Other healthcare associate professional

1.7

9.9

223

1383

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.6

9.9

288

1907

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

9.9

434

3144

N06AB10

ATC

escitalopram; oral

1.4

9.9

476

3507

J01MA12

ATC

levofloxacin; systemic

1.4

9.9

489

3621

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

9.9

189

1117

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

9.9

486

3595

L28

ICPC

Limited function/disability (L)

1.4

9.9

440

3196

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

9.8

703

5544

JN3AD

NOMESCO Finland

Abdominal CT examination

1.7

9.8

207

1260

DE2CM

NOMESCO Finland

Acoustic channel extensive MRI examination with 3 Tesla magnet

8.7

9.8

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

9.8

2623

24708

M54

ICD-10 Finland

Dorsalgia

1.6

9.7

283

1873

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.5

9.7

128

M01AC06

ATC

meloxicam; systemic, rectal

1.3

9.7

1020

8501

D09

ICPC

Nausea

2.2

9.7

457

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.3

9.7

360

K08.80

ICD-10 Finland

Toothache NOS

1.7

9.6

199

1204

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

9.6

357

2499

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.4

9.6

600

4624

TAB22

NOMESCO Finland

Stoppin epidural fluid escape with coagulated blood

4.0

9.6

H90.7

ICD-10 Finland

Mixed conductive and sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side

3.4

9.6

135

S82

ICPC

Naevus/mole

1.5

9.6

315

2146

U02

ICPC

Urinary frequency/urgency

1.5

9.6

363

2552

R05FA02

ATC

opium derivatives and expectorants; systemic

1.3

9.5

1110

9370

R06AE09

ATC

levocetirizine; oral

1.5

9.5

361

2537

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.5

9.5

330

2274

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

9.5

406

2926

K59.0

ICD-10 Finland

Constipation

1.8

9.5

150

837

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.6

9.4

231

1462

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.5

9.4

315

2153

J34.2

ICD-10 Finland

Deviated nasal septum

1.9

9.4

129

681

N03AE01

ATC

clonazepam; systemic

1.8

9.4

153

862

SPAT1360

SPAT

Extensive global examination

1.7

9.4

206

1267

L04

ICPC

Chest symptom/complaint

1.8

9.3

158

901

R03DC03

ATC

montelukast; oral

1.4

9.3

405

2924

WZA90

NOMESCO Finland

Other doctors statement

1.4

9.3

576

4430

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

3.3

9.3

138

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.1

9.3

467

H03AA01

ATC

levothyroxine sodium; systemic

1.3

9.3

656

5159

C07AB02

ATC

metoprolol; systemic

1.4

9.2

567

4356

H13

ICPC

Plugged feeling ear

1.4

9.2

481

3595

R06.4

ICD-10 Finland

Hyperventilation

3.0

9.2

167

D02

ICPC

Abdominal pain epigastric

1.8

9.2

155

883

G97.0

ICD-10 Finland

Cerebrospinal fluid leak from spinal puncture

3.6

9.2

108

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

9.2

172

1011

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.7

9.2

172

1011

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.1

9.1

451

D01

ICPC

Abdominal pain/cramps general

1.6

9.1

260

1712

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.3

9.1

135

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.4

9.1

584

4519

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

9.1

192

1170

A03FA02

ATC

cisapride; oral, rectal

1.6

9.1

218

1376

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

9.0

159

918

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.7

9.0

176

1048

A98

ICPC

Health maint/preventive medicine

1.5

9.0

2916

28065

K07.60

ICD-10 Finland

Snapping jaw

1.9

9.0

124

657

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

9.0

406

2953

H66.9

ICD-10 Finland

Otitis media, unspecified

1.9

8.9

130

706

J01

ICD-10 Finland

Acute sinusitis

1.9

8.9

121

640

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.9

8.8

133

729

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

8.8

964

8047

H29

ICPC

Ear symptom/complaint other

1.5

8.8

276

1858

78050

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Vertigo

3.4

8.8

123

H83.3

ICD-10 Finland

Noise effects on inner ear

9.5

8.8

N06AX16

ATC

venlafaxine; oral

1.5

8.7

329

2307

H71

ICD-10 Finland

Cholesteatoma of middle ear

3.6

8.7

103

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.7

8.7

166

980

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

8.7

263

1760

C10AA07

ATC

rosuvastatin; oral

1.3

8.7

654

5186

R06AX27

ATC

desloratadine; oral

1.3

8.6

655

5201

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

8.6

471

3549

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.7

8.6

177

1073

N03AX11

ATC

topiramate; oral

2.4

8.6

279

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.3

8.6

872

7210

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.8

8.6

134

743

M50.3

ICD-10 Finland

Other cervical disc degeneration

2.4

8.5

292

R31

ICD-10 Finland

Unspecified haematuria

1.6

8.5

241

1586

R35

ICD-10 Finland

Polyuria

1.7

8.5

166

991

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

1.7

8.5

154

900

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

2.1

8.5

457

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

8.4

342

2437

J45.9

ICD-10 Finland

Asthma, unspecified

1.4

8.4

462

3480

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.4

8.4

J01DC02

ATC

cefuroxime; systemic

1.8

8.4

146

840

H60

ICD-10 Finland

Otitis externa

2.0

8.4

111

579

H80.8

ICD-10 Finland

Other otosclerosis

+∞

8.3

38599

ICD-8 Finland

Ménière's disease

+∞

8.3

3870A

ICD-9 Finland

Otosclerosis involving oval window, nonobliterative

+∞

8.3

3861A

ICD-9 Finland

Vertiginous syndromes and other disorders of vestibular system, Other and unspecified peripheral vertigo

+∞

8.3

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

8.3

191

1194

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.5

8.3

255

1714

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

8.2

343

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.6

8.2

195

1226

N05AH04

ATC

quetiapine; oral

1.4

8.2

374

2724

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

8.2

424

3162

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.0

8.2

489

AA1BD

NOMESCO Finland

Extensive CT of head and brain

2.3

8.1

326

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

1.7

8.1

171

1040

T78.4

ICD-10 Finland

Allergy, unspecified

1.9

8.1

109

573

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

8.1

918

7682

G04CA02

ATC

tamsulosin; oral

1.4

8.0

503

3870

J01CA08

ATC

pivmecillinam; oral

1.3

8.0

1115

9570

H01

ICPC

Ear pain/earache

1.5

8.0

246

1654

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

8.0

1144

9851

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

7.9

235

1562

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

7.9

525

4074

S29

ICPC

Skin symptom/complaint other

1.4

7.9

433

3256

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

7.9

152

900

P20

ICPC

Memory disturbance

1.4

7.9

323

2304

R29

ICPC

Respiratory symptom/complaint other

1.7

7.9

157

942

I95.1

ICD-10 Finland

Orthostatic hypotension

2.0

7.9

458

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

7.9

749

6127

R06.5

ICD-10 Finland

Mouth breathing

1.6

7.8

202

1299

M48.0

ICD-10 Finland

Spinal stenosis

1.4

7.8

326

2331

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

1.6

7.8

180

1126

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.5

7.8

281

1954

7804A

ICD-9 Finland

General symptoms, Dizziness and giddiness

2.9

7.8

157

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

7.8

576

4551

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.6

7.7

207

1345

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

2.4

7.7

275

R50.9

ICD-10 Finland

Fever, unspecified

1.4

7.7

328

2363

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

1.8

7.6

121

677

K59.1

ICD-10 Finland

Functional diarrhoea

1.7

7.6

139

812

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

1.5

7.6

296

2090

D33.30

ICD-10 Finland

Acoustic neuroma

4.4

7.6

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.6

7.6

168

1040

A03

ICPC

Fever

1.4

7.6

346

2520

D10

ICPC

Vomiting

1.9

7.6

111

604

X58

ICD-10 Finland

Exposure to other specified factors

1.4

7.6

325

2340

H53.9

ICD-10 Finland

Visual disturbance, unspecified

2.1

7.5

370

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

7.5

175

1097

R03BA02

ATC

budesonide; inhalant

1.4

7.5

442

3367

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

2.6

7.5

202

L50.9

ICD-10 Finland

Urticaria, unspecified

2.0

7.5

457

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.7

7.5

160

983

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

7.4

296

2101

H53.2

ICD-10 Finland

Diplopia

2.1

7.4

401

J01FF01

ATC

clindamycin; systemic

1.3

7.4

704

5752

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

7.4

289

2045

R06.2

ICD-10 Finland

Wheezing

1.9

7.3

105

569

DFD30

NOMESCO Finland

Closure of perilymphatic fistula

+∞

7.3

3860A

ICD-9 Finland

Vertiginous syndromes and other disorders of vestibular system, Ménière's disease

+∞

7.3

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

7.3

474

R75

ICPC

Sinusitis acute/chronic

1.8

7.3

112

620

DE2DG

NOMESCO Finland

Acoustic channel very extensive MRI examination with high intensity magnet

15.8

7.2

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

7.2

222

1491

S02

ICPC

Pruritus

2.0

7.1

472

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

2.0

7.1

431

H25.8

ICD-10 Finland

Other senile cataract

1.4

7.1

295

2112

R52.2

ICD-10 Finland

Other chronic pain

2.0

7.1

459

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.6

7.1

164

1026

C08CA01

ATC

amlodipine; oral

1.2

7.1

972

8302

A01

ICPC

Pain general/multiple sites

1.6

7.1

200

1319

B01AC04

ATC

clopidogrel; oral

1.4

7.0

402

3046

C09CA01

ATC

losartan; oral

1.3

7.0

630

5107

N05BA12

ATC

alprazolam; oral

1.5

7.0

260

1819

DFF30

NOMESCO Finland

Loudness discomfort Level (LDL)

2.1

7.0

330

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.5

7.0

199

1316

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.7

7.0

148

905

J01DA06

ATC

[U] cefuroxime; systemic

1.4

6.9

371

2782

A06AC51

ATC

ispaghula, combinations; systemic

1.7

6.9

133

793

-48

ICPC

Clarification/discussion RFE/demand

2.3

6.9

259

R13

ICD-10 Finland

Dysphagia

1.6

6.9

167

1059

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

6.9

210

1410

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.9

6.9

506

3882A

ICD-9 Finland

Other disorders of ear, Sudden hearing loss, unspecified

13.8

6.9

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.2

6.9

1291

11398

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.8

6.8

112

633

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.3

6.8

517

4090

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

6.8

157

984

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.0

6.8

414

H01.0

ICD-10 Finland

Blepharitis

1.7

6.8

126

740

A05

ICPC

Feeling ill

1.8

6.8

119

688

DHB50

NOMESCO Finland

Turbinoplasty

2.3

6.8

266

H83.9

ICD-10 Finland

Disease of inner ear, unspecified

40.1

6.8

N89

ICPC

Migraine

2.3

6.8

247

P03

ICPC

Feeling depressed

1.6

6.7

181

1179

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.7

1823

16691

U05

ICPC

Urination problems other

1.7

6.7

120

697

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

6.7

139

844

N04BC05

ATC

pramipexole; oral

1.5

6.7

196

1304

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

6.7

1046

9047

S02CA02

ATC

flumetasone and antiinfectives; otic

1.7

6.7

141

864

TAB00

NOMESCO Finland

Lumbar puncture

1.8

6.7

107

600

Z71.8

ICD-10 Finland

Other specified counselling

1.3

6.7

572

4604

R25.2

ICD-10 Finland

Cramp and spasm

2.2

6.7

270

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.7

267

1897

ND1BA

NOMESCO Finland

Wrist extensive X-ray examination

2.2

6.7

315

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

6.7

515

4085

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

1.9

6.7

455

R07.0

ICD-10 Finland

Pain in throat

1.7

6.6

130

779

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.3

6.6

262

R03AK08

ATC

formoterol and beclometasone; inhalant

1.8

6.6

544

R30.0

ICD-10 Finland

Dysuria

1.9

6.6

457

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

1.8

6.6

101

560

SPAT1211

SPAT

Application of soft bandage

1.5

6.6

224

1538

PA6AD

NOMESCO Finland

CT of neck arteries

2.8

6.6

140

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.6

608

4942

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.5

6.6

209

1418

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.5

6.6

185

1219

R00.8

ICD-10 Finland

Other and unspecified abnormalities of heart beat

2.9

6.6

124

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

2.9

6.6

124

SHA04

NOMESCO Finland

Correction of physiology of bite - very demanding therapy visit

3.0

6.5

113

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

6.5

163

1041

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

6.5

319

2353

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.4

6.5

311

2284

A02BA04

ATC

nizatidine; systemic

1.5

6.5

201

1352

S92.3

ICD-10 Finland

Fracture of metatarsal bone

2.0

6.5

411

G81.9

ICD-10 Finland

Hemiplegia, unspecified

3.4

6.5

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

6.5

155

982

M01AH02

ATC

rofecoxib; oral

1.4

6.5

350

2627

D12

ICPC

Constipation

1.9

6.5

440

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.5

6.5

225

1555

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

6.5

792

6662

I47.9

ICD-10 Finland

Paroxysmal tachycardia, unspecified

2.5

6.4

184

N05BA01

ATC

diazepam; systemic, rectal

1.4

6.4

331

2463

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

6.4

209

1424

G04BD12

ATC

mirabegron; oral

1.4

6.4

268

1922

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.8

6.4

107

613

R01AD05

ATC

budesonide; nasal

1.5

6.4

191

1277

SPAT1260

SPAT

Consultation of another employee

1.3

6.4

465

3658

G43.8

ICD-10 Finland

Other migraine

2.8

6.3

138

C10AA01

ATC

simvastatin; oral

1.2

6.3

1202

10596

M01AB55

ATC

diclofenac, combinations; oral

1.5

6.3

184

1221

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

6.3

336

2516

F51.0

ICD-10 Finland

Nonorganic insomnia

1.4

6.3

287

2091

N03AF02

ATC

oxcarbazepine; oral

2.0

6.3

361

N03AX09

ATC

lamotrigine; oral

1.8

6.3

100

565

DFD20

NOMESCO Finland

Closure of rupture of round window

+∞

6.2

DFA00

NOMESCO Finland

Saccotomy

+∞

6.2

C10AA03

ATC

pravastatin; oral

1.5

6.2

186

1241

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.4

6.2

360

2731

K04.00

ICD-10 Finland

Hyperemia of pulp

1.9

6.2

492

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

1.8

6.2

522

F32

ICD-10 Finland

Depressive episode

1.7

6.2

112

656

N03AF01

ATC

carbamazepine; oral, rectal

1.7

6.2

129

790

M01AH01

ATC

celecoxib; oral (coxibs)

1.3

6.2

486

3866

C01DA14

ATC

isosorbide mononitrate; oral

1.3

6.2

392

3020

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.5

6.1

198

1347

L14

ICPC

Leg/thigh symptom/complaint

1.5

6.1

188

1267

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.8

6.1

547

CS494

NOMESCO Finland

Other visual field testing

2.2

6.1

268

D03

ICPC

Heartburn

1.9

6.1

431

XKD06

NOMESCO Finland

Physiologic investigation of micturition

2.0

6.1

392

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.2

6.0

281

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

6.0

613

5039

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

6.0

238

1689

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.5

6.0

170

1123

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

6.0

101

577

SPAT1229

SPAT

Assessment of need for aid

1.5

6.0

208

1435

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1731

11550

1.98

83.62

4.6

3.7

ng/l

31.1

93.5

0.95

1242

8141

(3013512) EKG study

1426

8948

2.00

81.77

4.7

4.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1432

9215

1.93

74.40

2.3

2.1

u/l

133.9

211.1

5.26

1362

8601

(3013826) Glucose [Moles/volume] in Serum or Plasma

2303

17661

1.87

65.64

4.6

mmol/l

6.6

6.8

3.79

2192

16509

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

693

3789

2.03

55.13

5.1

4.6

32.0

32.9

1.38

477

2537

(3037467) Urinalysis macro (dipstick) panel - Urine

2529

20590

1.80

52.34

5.0

4.5

—

(3032080) INR in Blood by Coagulation assay

1696

12380

1.71

51.88

10.1

9.7

inr

1.3

0.02

472

3487

(3013707) Erythrocyte sedimentation rate by Westergren method

2660

22175

1.81

48.53

4.9

4.1

mm/h

11.6

13.1

7.22

2447

20441

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3269

29352

2.51

47.15

17.6

15.0

mg/l

18.7

24.2

23.92

2721

23438

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2748

23293

1.81

45.40

7.6

7.7

u/l

74.9

79.1

7.58

2561

21927

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1344

9469

1.68

45.00

2.5

2.6

u/l

58.7

57.7

0.15

1202

8720

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1837

14023

1.65

44.83

5.2

5.9

mmol/l

1.2

2.54

1621

12650

(3031040) Bacteria [#/volume] in Urine by Automated count

2434

19973

1.70

44.75

5.6

4.7

e6/l

133.1

2211.6

4.63

287

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1985

15467

1.65

44.51

5.9

6.7

mmol/l

1.2

3.68

1633

13031

(3019550) Sodium [Moles/volume] in Serum or Plasma

3345

30493

2.80

44.32

20.1

17.3

mmol/l

139.7

139.6

0.49

3273

29723

(3019225) pH of Specimen

575

3163

1.98

44.08

3.9

4.5

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3348

30572

2.80

43.48

20.2

17.4

mmol/l

4.0

1.96

3262

29753

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3076

27226

2.00

41.66

5.9

4.9

mu/l

1.9

2.1

1.94

2788

24812

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2260

18656

1.59

36.05

3.4

3.1

u/l

44.9

50.0

2.47

2058

17236

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

954

6517

1.64

33.95

1.8

1.7

mg/l

0.9

1.3

4.93

713

5004

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3043

27295

1.83

33.08

6.4

5.9

mmol/mol

39.8

40.0

0.53

2751

25116

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1964

15892

1.53

32.68

5.5

6.2

umol/l

11.0

11.4

0.94

1831

15081

(3018677) aPTT in Platelet poor plasma by Coagulation assay

712

4599

1.69

31.14

1.8

2.1

29.2

29.9

2.43

694

4461

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2647

22998

1.60

31.05

4.8

4.1

pmol/l

15.0

14.9

1.33

2374

20828

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1629

12765

1.51

30.84

2.1

2.0

pmol/l

100.2

95.2

3.15

834

6474

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3156

28762

1.91

30.78

5.3

4.7

mmol/l

6.0

0.19

2833

26082

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1228

9063

1.54

30.76

3.1

3.0

ng/l

1110.7

1470.1

3.52

1027

7831

(40761511) CBC panel - Blood by Automated count

3286

30401

2.15

30.19

17.5

14.1

—

(42870588) Differential panel, method unspecified - Blood

1349

10193

1.52

30.15

5.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3344

31205

2.33

29.17

12.1

10.8

u/l

25.6

25.3

0.30

3202

30045

(40768797) Stomach Pathology biopsy report

648

4197

1.67

27.70

1.2

—

(3007461) Platelets [#/volume] in Blood

3414

32322

2.64

25.78

26.3

22.1

e9/l

248.9

251.8

1.91

3352

31452

(3010813) Leukocytes [#/volume] in Blood

3415

32341

2.65

25.68

26.4

22.2

e9/l

6.7

6.8

0.13

3348

31357

(3024731) MCV [Entitic volume]

3414

32334

2.63

25.54

26.2

22.1

91.0

91.3

3.67

3375

31824

(3035941) MCH [Entitic mass]

3414

32335

2.63

25.52

26.2

22.0

30.3

0.41

3374

31823

(3026361) Erythrocytes [#/volume] in Blood

3414

32338

2.63

25.46

26.3

22.1

e12/l

4.5

4.4

3.11

3346

31360

(3000963) Hemoglobin [Mass/volume] in Blood

3414

32348

2.62

25.25

26.5

22.3

g/l

134.5

133.7

3.08

3374

31844

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3044

27770

1.69

25.23

16.4

14.0

ml/min/173m2

78.3

78.4

0.08

2623

22932

(3022217) INR in Platelet poor plasma by Coagulation assay

615

4058

1.62

24.11

25.9

inr

1.4

0.55

560

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

323

1775

1.90

24.10

1.3

au/ml

36.3

47.2

0.44

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

873

6253

1.53

23.90

1.3

1.2

u/ml

1.5

1.6

0.17

193

1621

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

345

1961

1.84

23.14

2.6

2.4

au/ml

18.3

25.3

0.32

(3018010) Neutrophils/100 leukocytes in Blood

1715

14076

1.42

22.90

6.0

5.9

56.9

57.6

1.56

1586

13099

(3002030) Lymphocytes/100 leukocytes in Blood

1734

14289

1.42

22.48

6.3

6.1

28.2

27.5

1.76

1587

13238

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

821

5880

1.52

22.25

4.5

3.7

ng/l

157.5

388.7

3.75

634

4710

(3007164) IgA [Mass/volume] in Serum or Plasma

772

5459

1.53

22.21

1.4

1.5

g/l

2.3

2.5

2.06

432

3265

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3179

29550

1.75

22.02

5.6

5.0

mmol/l

2.7

0.15

2897

27038

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1566

12705

1.42

22.01

2.4

2.2

nmol/l

78.2

78.9

0.48

1392

11323

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

723

5052

1.54

21.94

1.4

1.3

iu/ml

39.3

34.7

0.31

223

1554

(3006504) Eosinophils/100 leukocytes in Blood

1688

13905

1.41

21.59

6.2

6.0

2.8

0.08

1562

12898

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3016

27687

1.61

21.55

4.5

4.0

mmol/l

1.3

4.41

2717

25091

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3104

28698

1.67

21.55

5.1

4.5

mmol/l

1.4

1.5

7.12

2822

26228

(3019069) Monocytes/100 leukocytes in Blood

1695

13983

1.41

21.44

6.6

6.3

8.4

8.7

2.62

1577

13027

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3123

28931

1.68

21.37

5.1

4.5

mmol/l

4.6

4.7

0.60

2845

26615

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1993

16962

1.40

20.70

3.0

2.8

—

(3048689) Calprotectin [Mass/mass] in Stool

513

3362

1.62

20.41

2.3

2.2

ug/g

131.3

136.1

0.10

409

2616

(3009343) pH of Capillary blood

316

1855

1.77

18.95

3.1

3.7

7.4

0.24

239

(3022096) Basophils/100 leukocytes in Blood

1626

13520

1.38

18.62

6.3

6.0

0.7

0.44

1502

12550

(3024561) Albumin [Mass/volume] in Serum or Plasma

1605

13326

1.37

18.50

3.8

4.8

g/l

35.7

35.2

3.82

1440

12352

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

218

1147

1.96

18.46

3.4

4.0

mmol/l

25.0

24.9

0.29

192

1050

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

317

1878

1.76

18.41

3.1

3.7

kpa

5.2

0.08

290

1738

(3044640) Blood type and Crossmatch panel - Blood

1223

9761

1.39

17.77

2.3

2.4

—

(3013115) Eosinophils [#/volume] in Blood

1808

15365

1.36

17.67

6.0

e9/l

0.2

1.02

1585

13412

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

302

1787

1.75

17.60

3.1

3.6

mmol/l

1.6

1.9

0.82

234

1332

(3026782) Osmolality of Urine

802

5960

1.45

17.45

3.2

2.8

mosm/kgh2o

534.5

538.4

0.20

667

5079

(3022313) Gas panel - Capillary blood

241

1340

1.86

17.26

3.2

3.9

—

(3019309) Folate [Moles/volume] in Red Blood Cells

799

5958

1.44

17.01

1.9

1.8

nmol/l

1106.1

1180.2

1.42

590

4491

(3006315) Basophils [#/volume] in Blood

1748

14862

1.35

16.61

6.0

5.8

e9/l

0.0

0.49

1534

12763

(3013650) Neutrophils [#/volume] in Blood by Automated count

1996

17328

1.35

16.44

8.0

9.1

e9/l

4.1

0.36

1747

15115

(3019198) Lymphocytes [#/volume] in Blood

1776

15171

1.34

16.18

6.0

5.8

e9/l

2.0

1.9

0.42

1578

13275

(3015377) Calcium [Moles/volume] in Serum or Plasma

1310

10690

1.36

16.16

2.8

3.4

mmol/l

2.4

0.01

1088

9264

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

662

4812

1.46

16.02

1.4

1.2

u/ml

16.8

11.7

0.31

232

1821

(3018095) Leukocytes [#/volume] in Urine

1304

10649

1.36

15.95

4.2

3.7

e6/l

97.0

114.2

0.36

965

7551

(3026008) Bacteria identified in Urine by Culture

1208

9750

1.36

15.93

3.4

3.3

—

(3000850) Epithelial cells [#/volume] in Urine

839

6378

1.41

15.90

2.9

2.6

e6/l

5.6

5.9

0.42

712

5589

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

275

1647

1.73

15.33

2.4

—

(3001604) Monocytes [#/volume] in Blood

1729

14794

1.33

15.19

5.9

5.8

e9/l

0.6

0.91

1526

12692

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1495

12540

1.33

15.01

3.0

2.8

ug/l

116.7

127.9

0.74

1362

11539

(3036481) Cortisol [Moles/volume] in Serum or Plasma

406

2700

1.57

14.95

2.1

nmol/l

365.1

373.4

0.40

362

2472

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

953

7473

1.38

14.85

2.2

2.4

—

(40768804) Tissue Pathology biopsy report

1481

12436

1.33

14.64

2.2

2.1

—

(3002582) Erythrocytes [#/volume] in Urine

1130

9128

1.35

14.50

3.7

3.2

e6/l

172.1

84.3

0.39

895

7011

(3017732) Neutrophils [#/volume] in Blood

321

2033

1.64

14.48

2.7

3.1

e9/l

3.8

4.1

1.52

228

1553

(3037522) Nuclear Ab [Titer] in Serum

541

3872

1.47

14.03

1.4

1.3

titre

538.3

542.8

0.02

118

857

(3003327) Ova and parasites identified in Stool by Light microscopy

167

892

1.92

13.57

1.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

405

2.36

13.34

2.0

2.2

mg/l

26.3

21.5

0.37

100

(3030467) Casts [#/volume] in Urine by Automated count

1043

8410

1.34

13.30

3.6

3.1

e6/l

0.4

0.5

0.23

804

6354

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

976

7823

1.34

12.87

2.4

2.2

mg/l

2.9

3.0

0.45

820

6645

(36304419) Bacteria [Presence] in Urine

1014

8175

1.34

12.86

3.5

3.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

589

4355

1.42

12.74

1.5

1.4

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1647

14258

1.29

12.21

4.0

4.1

—

(3005322) IgE [Units/volume] in Serum or Plasma

270

1715

1.62

12.02

1.3

u/ml

95.6

201.4

5.36

252

1571

(3022145) Colonoscopy Study observation

467

3346

1.46

11.93

1.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

913

7314

1.33

11.93

1.6

nmol/l

21.4

20.7

0.69

756

6225

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

848

6738

1.34

11.68

1.8

1.7

pmol/l

34168325.6

31319015.7

0.05

679

5559

(3025941) Bacteria identified in Stool by Culture

255

1620

1.62

11.35

1.3

—

(36660697) Celiac disease serology panel - Serum

326

2233

1.51

10.41

1.2

—

(3009542) Hematocrit [Volume Fraction] of Blood

2792

26150

1.32

10.06

17.5

16.2

39.5

39.2

0.99

1784

18031

(3049717) Cytology report of Urine Cyto stain

187

1140

1.68

9.81

2.5

2.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

298

2029

1.51

9.79

1.3

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

650

5090

1.34

9.67

2.0

1.8

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

221

1416

1.60

9.52

1.1

1.0

—

(4010399)

305

2110

1.49

9.27

1.5

1.4

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

195

1221

1.63

9.23

1.9

1.8

u/l

39.1

39.2

0.01

167

1080

(3035350) Ketones [Presence] in Urine by Test strip

1647

14570

1.24

9.14

4.2

3.8

estimate

0.0

0.50

310

2682

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

459

3436

1.39

9.07

2.3

2.6

umol/l

7.4

8.7

0.42

396

2979

(3012095) Magnesium [Moles/volume] in Serum or Plasma

630

4956

1.33

9.03

2.5

3.2

mmol/l

0.8

0.20

572

4608

(3015736) pH of Urine

1313

11339

1.25

9.01

3.8

3.6

—

5.8

—

(3021601) Nitrite [Presence] in Urine by Test strip

1647

14595

1.24

8.92

5.7

5.1

estimate

0.0

0.50

318

2715

(3026493) Urate [Moles/volume] in Serum or Plasma

940

7821

1.28

8.81

2.4

2.7

umol/l

3206.7

5499.8

1.16

768

6730

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

149

881

1.72

8.78

1.5

1.6

g/l

1.2

0.33

143

836

(3009261) Glucose [Presence] in Urine by Test strip

1664

14781

1.24

8.75

4.4

3.9

estimate

0.0

0.80

320

2662

(4024509)

323

2.19

8.59

1.8

1.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

191

1222

1.60

8.31

2.0

1.8

—

(3018418) pH of Serum or Plasma

1087

9265

1.25

8.19

3.6

4.1

7.4

0.74

228

1748

(3032057) Clostridioides difficile [Presence] in Stool

3.77

8.06

1.8

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

203

1327

1.56

8.06

2.2

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

4.14

7.99

1.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

136

807

1.71

7.94

1.3

1.2

u/ml

9.7

41.4

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

121

2.91

7.85

1.1

1.0

u/ml

7.6

6.7

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

101

3.09

7.70

1.2

g/l

0.3

0.32

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

128

2.83

7.68

1.2

1.3

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

123

717

1.74

7.66

1.5

1.3

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

359

2.06

7.65

1.5

1.4

u/l

33.5

32.2

0.10

302

(3033658) Prothrombin time (PT) actual/Normal

910

7667

1.25

7.47

3.7

3.8

90.1

89.8

0.10

891

7472

(3041096) Erythrocytes [Presence] in Urine by Automated

911

7694

1.25

7.30

4.2

3.5

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

140

860

1.65

7.21

1.5

1.6

g/l

0.2

1.20

134

815

(3005719) IgG [Mass/volume] in Serum or Plasma

304

2209

1.41

7.14

2.4

2.8

g/l

10.0

10.6

1.54

273

2014

(40761536) Microorganisms panel - Urine sediment

342

2536

1.39

7.13

5.1

4.1

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

598

4815

1.29

7.11

3.1

2.9

e6/l

3.3

2.8

0.41

355

2598

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

400

1.95

6.96

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

166

1075

1.57

6.91

1.5

1.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

636

5186

1.28

6.82

2.9

2.7

e6/l

1.1

1.2

0.52

389

2947

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

696

1.70

6.82

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

172

1128

1.55

6.78

1.3

1.2

u/ml

1.5

1.3

0.07

105

(3000494) Fungus identified in Specimen by Culture

447

3483

1.32

6.75

1.5

1.4

—

(44806071)

4.70

6.68

1.0

1.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

392

1.93

6.68

1.5

—

(3023368) Bacteria identified in Blood by Culture

976

8380

1.23

6.60

4.2

4.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

124

758

1.66

6.54

1.3

u/ml

4.8

7.5

0.45

138

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

395

1.92

6.54

1.5

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

262

1886

1.42

6.50

1.7

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

397

1.91

6.44

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

391

1.91

6.40

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

391

1.91

6.40

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

143

912

1.59

6.37

1.5

1.4

ug/g

267.2

276.0

0.19

524

(4034850)

151

978

1.57

6.31

6.9

10.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

305

2270

1.38

6.23

1.7

1.6

—

(3044290) Cell count panel - Cerebral spinal fluid

556

1.75

6.19

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

929

7991

1.22

6.09

1.7

1.6

mmol/l

1.4

0.56

762

6673

(3009508) Creatinine [Moles/volume] in Urine

1072

9369

1.21

5.95

3.1

3.2

mmol/l

7.3

7.2

0.50

855

7848

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1254

11138

1.20

5.81

4.7

4.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

119

745

1.62

5.76

1.3

1.2

u/ml

4.4

2.9

—

(3002032) Base excess in Venous blood by calculation

362

2800

1.33

5.75

3.3

3.6

mmol/l

2.1

2.0

0.20

303

2272

(1001926) Buprenorphine [Presence] in Urine by Screen method

481

1.76

5.66

1.7

—

(3012501) Base excess in Blood by calculation

112

694

1.63

5.66

4.5

4.6

mmol/l

2.6

2.7

0.24

491

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

251

1839

1.39

5.65

1.9

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

258

1903

1.38

5.59

1.3

1.2

iu/ml

108.9

155.1

1.29

687

(4015189)

2.94

5.56

2.0

2.3

—

(40768443) Skin Pathology biopsy report

192

1347

1.45

5.52

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

184

2.24

5.50

1.2

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

428

1.79

5.44

1.3

nmol/l

0.6

0.7

0.44

411

(3012516) Albumin [Mass/volume] in Urine

1027

9005

1.20

5.41

3.1

3.3

mg/l

387.4

309.2

0.20

607

5624

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

118

751

1.59

5.36

1.9

2.0

mg/l

11.1

11.7

0.29

108

682

(3030981) Hyaline casts [#/volume] in Urine by Automated count

213

1533

1.41

5.33

2.9

2.8

e6/l

0.2

0.3

1.40

207

1492

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

187

2.21

5.31

1.2

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

373

1.84

5.30

1.5

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

240

2.06

5.30

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

181

2.22

5.28

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1075

9483

1.19

5.27

3.9

4.0

mg/mmol

7.0

9.0

1.10

627

5905

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

399

1.80

5.13

1.3

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

436

1.76

5.13

1.3

nmol/l

0.1

0.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

926

8079

1.20

5.10

5.6

5.1

ug/l

2.8

3.1

0.40

820

7178

(3022806) Fractional oxyhemoglobin in Capillary blood

408

1.78

5.07

2.5

1.9

91.2

89.3

3.61

403

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

613

1.63

5.05

1.3

1.2

mmol/l

3.8

0.10

575

(3011288) Drugs identified in Urine by Screen method

416

1.77

5.05

2.7

2.5

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

614

1.63

5.02

1.2

u/ml

3.0

3.4

—

(3027008) Opiates [Presence] in Urine

100

622

1.63

5.02

1.7

—

(3008898) HLA-B27 [Presence]

129

852

1.53

5.01

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

147

2.33

5.00

1.1

1.3

nmol/l

132.9

134.8

0.11

147

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

388

1.79

4.99

1.2

1.1

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

343

2689

1.31

4.96

3.1

3.0

ng/l

136.3

203.2

6.02

323

2453

(3033705) Calcium.ionized [Moles/volume] in Venous blood

390

1.78

4.91

2.7

2.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

270

2050

1.34

4.89

2.0

1.9

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1073

9515

1.18

4.88

2.8

3.2

u/l

33.2

37.1

0.64

1000

9021

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

334

2618

1.30

4.84

3.7

3.9

mmol/l

1.2

0.18

298

2268

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

108

691

1.58

4.84

1.4

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

3.00

4.82

1.1

1.2

umol/24h

0.6

0.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

430

3483

1.27

4.82

1.9

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

240

1794

1.36

4.82

1.5

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

314

2444

1.31

4.79

2.6

3.7

ng/l

75.9

90.8

3.43

262

2078

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

372

1.79

4.75

1.5

1.3

pmol/l

246.5

270.2

0.34

294

(3021447) Carbon dioxide [Partial pressure] in Venous blood

355

2813

1.29

4.74

3.3

3.5

kpa

5.8

0.51

349

2727

(3024980) IgG subclass 4 [Mass/volume] in Serum

433

1.72

4.69

1.7

g/l

0.6

0.8

2.00

328

(3016879) Cocaine [Presence] in Urine

571

1.63

4.68

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

626

1.60

4.67

1.7

—

(3023511) Choriogonadotropin [Units/volume] in Urine

345

1.81

4.66

1.4

1.3

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

375

1.77

4.64

1.2

1.3

nmol/l

—

(3000764) Benzodiazepines [Presence] in Urine

620

1.60

4.62

1.7

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

356

2834

1.28

4.59

2.7

2.4

u/l

33.4

39.1

0.50

298

2424

(3027944) Amphetamines [Presence] in Urine

613

1.60

4.59

1.5

1.7

—

(3010421) pH of Blood

123

822

1.51

4.56

4.3

7.4

1.08

110

682

(3026389) Candida sp identified in Specimen by Organism specific culture

422

1.72

4.55

1.3

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

3.60

4.48

1.0

1.1

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

201

2.05

4.48

1.3

1.1

mg/l

33.2

42.5

0.88

170

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

579

1.60

4.44

1.2

u/ml

39.4

41.9

0.05

(40767503) Oxygen content in Capillary blood by calculation

101

652

1.57

4.39

2.9

2.5

16.6

15.9

0.80

335

(3023323) Follitropin [Units/volume] in Serum or Plasma

156

1104

1.43

4.35

1.4

1.3

iu/l

28.1

32.2

0.87

125

945

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

113

2.40

4.30

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

132

908

1.47

4.27

1.5

1.8

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

126

2.31

4.26

1.1

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

133

918

1.47

4.23

1.2

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

212

1590

1.35

4.20

2.2

nmol/l

11.3

12.2

0.80

177

1394

(4094501)

118

797

1.50

4.19

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

230

1748

1.34

4.18

1.7

1.9

g/l

1.2

1.4

1.12

209

1590

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

441

1.67

4.16

1.4

1.6

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

202

1506

1.36

4.16

3.5

3.1

mmol/l

25.5

25.4

0.11

195

1456

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

2.67

4.15

2.3

2.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

244

1873

1.33

4.14

3.4

2.9

g/l

133.3

127.5

4.53

238

1825

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

250

1.89

4.11

1.8

1.6

—

(1616796) Gas panel - Central venous blood

103

681

1.53

4.05

3.1

3.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

394

3230

1.25

3.99

4.2

3.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

682

5907

1.19

3.98

2.8

3.1

mmol/l

2.4

2.5

1.75

569

5169

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.43

3.96

3.7

2.9

umol/l

27.7

28.8

0.22

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

144

2.16

3.92

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

144

2.16

3.92

1.4

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

178

2.03

3.89

1.1

nmol/l

1.0

5.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

461

3858

1.22

3.86

7.0

7.2

—

(4146454)

337

1.73

3.84

2.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

291

2313

1.28

3.83

3.2

2.9

kpa

4.4

4.6

0.65

286

2233

(44813793)

186

2.00

3.82

1.1

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

128

897

1.44

3.80

1.6

1.7

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.80

1.0

1.2

—

(3021589) Normoblasts [#/volume] in Blood

1426

13122

1.15

3.76

11.2

9.7

e9/l

0.0

1.62

1205

10678

(3004616) Nuclear Ab [Presence] in Serum

377

1.68

3.76

1.3

1.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

154

2.09

3.72

1.2

1.0

u/l

1.1

0.42

(3015235) Bicarbonate [Moles/volume] in Capillary blood

112

770

1.47

3.68

2.2

3.2

mmol/l

25.1

25.0

0.02

100

671

(3004588) Protein electrophoresis panel - Serum or Plasma

277

2200

1.28

3.68

1.8

2.5

—

(3020630) Protein [Mass/volume] in Serum or Plasma

325

2633

1.26

3.66

1.9

2.7

g/l

66.5

66.4

0.07

283

2410

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

156

1141

1.38

3.65

1.7

1.8

—

(3045414) Leukocytes [Presence] in Urine

187

1408

1.35

3.65

1.9

2.0

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

487

4122

1.21

3.64

2.3

2.6

21.9

22.4

0.37

410

3507

(3038515) Glucose [Moles/volume] in Venous blood

658

1.50

3.63

4.8

3.2

mmol/l

7.5

7.6

0.19

641

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

2.87

3.62

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

3.44

3.61

1.1

1.2

umol/24h

1.6

1.8

0.44

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

237

1849

1.30

3.61

3.2

3.3

pmol/l

4.4

0.71

205

1635

(3000330) Specific gravity of Urine by Test strip

210

1612

1.32

3.60

3.9

3.5

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

327

2657

1.25

3.60

2.6

2.4

ug/l

6.3

7.0

0.25

270

2337

(3045424) Erythrocytes [Presence] in Urine

524

1.56

3.56

1.5

1.6

—

(3002256) Pathology report gross observation

478

4048

1.21

3.55

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

573

1.53

3.53

1.3

u/l

9.7

12.3

1.28

464

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

172

1287

1.35

3.51

4.6

5.3

1.7

1.6

0.32

162

1205

(3028707) Methadone [Presence] in Urine by Screen method

279

1.77

3.50

2.0

2.1

—

(3029937) Albumin [Presence] in Urine by Test strip

888

7940

1.16

3.46

4.9

4.3

estimate

0.0

0.24

322

2628

(1761868) Lipid panel - Serum or Plasma

1065

9652

1.15

3.43

3.4

2.9

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

170

1275

1.35

3.42

4.6

5.3

0.8

0.9

1.95

160

1196

(3028192) IgG subclass 2 [Mass/volume] in Serum

274

1.76

3.41

1.5

1.4

g/l

2.9

0.01

194

(3027135) IgG subclass 1 [Mass/volume] in Serum

274

1.76

3.41

1.5

1.4

g/l

6.3

7.1

0.76

193

(3024139) IgG subclass 3 [Mass/volume] in Serum

274

1.76

3.41

1.5

1.4

g/l

0.4

0.11

194

(3022948) Iron [Moles/volume] in Serum or Plasma

557

4802

1.19

3.41

2.3

2.5

umol/l

13.0

12.8

0.22

501

4447

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.84

3.35

1.5

1.1

—

(4062490)

276

1.75

3.34

1.5

1.4

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

141

1032

1.38

3.32

2.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

299

1.72

3.31

2.2

2.8

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

515

4426

1.19

3.27

2.2

2.5

g/l

2.4

2.3

2.81

469

4093

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

406

3414

1.21

3.25

3.0

4.0

ug/l

11.4

25.9

1.34

324

2776

(3011985) Renin [Units/volume] in Plasma

393

1.61

3.25

1.4

mu/l

21.5

49.9

2.38

346

(40760892) CBC W Ordered Manual Differential panel - Blood

719

6370

1.16

3.14

4.6

4.5

—

(3000492) Spirometry study

323

2664

1.23

3.13

1.5

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.96

3.13

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

107

755

1.43

3.13

1.0

1.1

u/ml

2.5

6.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

141

1048

1.36

3.05

1.8

2.2

ug/l

368.4

685.1

0.55

129

984

(3008037) Lactate [Moles/volume] in Venous blood

100

701

1.44

3.04

4.8

3.1

mmol/l

1.6

0.14

100

682

(3019060) Gas panel - Arterial blood

257

2074

1.26

3.04

4.0

4.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

168

1.91

2.99

1.0

1.1

iu/ml

9.7

9.9

—

(3014271) Vancomycin [Susceptibility]

161

1.93

2.99

3.3

3.0

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

226

1.78

2.98

1.6

1.5

u/ml

25.6

17.8

—

(3000475) Leukocytes [#/volume] in Synovial fluid

105

747

1.42

2.95

1.6

e6/l

10276.0

12954.8

0.37

534

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

413

3514

1.20

2.94

1.8

1.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

104

741

1.42

2.90

1.8

1.6

mu/l

367.5

308.0

0.52

668

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

135

2.01

2.90

1.6

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

460

3967

1.18

2.81

3.8

5.8

mmol/l

1.0

1.85

420

3675

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

604

1.45

2.80

1.6

1.4

e6/l

436.6

1419.5

1.04

492

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

604

1.45

2.80

1.4

1.3

e6/l

12.0

28.9

0.84

464

(3017354) Segmented neutrophils/100 leukocytes in Blood

315

1.63

2.78

4.2

3.6

61.9

57.6

0.60

197

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.27

2.77

1.6

1.5

ug/l

0.4

0.05

(3051593) INR in Capillary blood by Coagulation assay

159

1.89

2.75

4.5

13.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

516

1.48

2.75

3.9

3.7

0.9

1.4

1.85

398

(3014111) Lactate [Moles/volume] in Serum or Plasma

318

2659

1.22

2.73

4.9

6.4

mmol/l

1.4

0.06

308

2560

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

428

1.53

2.72

1.1

—

(3037121) Protein [Mass/volume] in Urine

141

1072

1.33

2.67

3.7

3.1

g/l

0.3

0.16

419

(3003181) Sodium [Moles/volume] in Urine

586

1.44

2.66

1.6

1.3

mmol/l

73.0

62.4

1.34

473

(3020874) Milk IgE Ab [Units/volume] in Serum

119

2.02

2.65

1.0

1.1

u/ml

0.5

1.0

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

412

3539

1.19

2.65

3.9

4.2

u/l

242.5

249.4

0.55

385

3338

(3014051) Protein [Presence] in Urine by Test strip

101

730

1.39

2.63

2.2

—

(40761535) Cells panel - Urine sediment

309

2587

1.21

2.62

4.2

3.6

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

155

1.88

2.61

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

162

1262

1.30

2.58

1.9

2.0

ug/l

1.6

2.4

0.53

132

1115

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

178

1404

1.28

2.58

4.9

3.7

49.4

48.6

0.19

178

1386

(3014765) Yersinia sp identified in Stool by Organism specific culture

119

888

1.35

2.56

1.3

1.2

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

114

2.02

2.56

1.1

1.0

u/ml

0.6

0.4

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

7.15

2.55

1.2

1.1

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

176

1391

1.28

2.52

2.8

3.9

mmol/l

24.5

24.2

0.80

161

1244

(3039162) Centromere protein B Ab [Units/volume] in Serum

356

1.55

2.51

1.3

u/ml

45.1

62.9

—

(3003129) Base excess in Capillary blood by calculation

2.27

2.50

1.3

2.2

mmol/l

1.0

1.5

0.21

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

194

1.76

2.50

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

357

3047

1.19

2.48

1.6

1.7

—

(3027945) Reticulocytes/100 erythrocytes in Blood

407

3515

1.18

2.46

2.2

2.5

1.8

0.40

349

3106

(42529406) Shigella sp [Presence] in Stool by Culture

119

895

1.34

2.45

1.3

1.2

—

(3036489) Thrombin time

137

1053

1.31

2.43

1.8

1.9

21.7

21.6

0.06

111

919

(3016502) Oxygen saturation in Arterial blood

368

3156

1.19

2.42

5.7

7.3

96.0

95.6

0.64

354

3041

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

406

3511

1.18

2.42

1.9

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

336

1.56

2.40

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

153

1.84

2.38

2.6

2.4

—

(4027681)

153

1.84

2.38

1.3

1.2

—

(40758558) Short blood count panel - Blood

845

7707

1.13

2.37

6.2

6.8

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

198

1605

1.25

2.32

6.2

8.8

mmol/l

24.6

24.4

0.51

182

1495

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

117

886

1.33

2.32

1.6

iu/ml

0.5

7.3

0.54

189

(4198724)

2.31

1.1

1.8

—

(3016018) Differential panel - Cerebral spinal fluid

284

1.59

2.31

1.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

200

1.71

2.28

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.69

2.27

2.0

2.2

—

(3003396) Base excess in Arterial blood by calculation

408

3551

1.17

2.26

5.4

6.9

mmol/l

1.3

1.2

0.28

321

2766

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

127

1.90

2.25

2.0

1.9

—

(3040151) Glucose [Moles/volume] in Capillary blood

334

1.53

2.24

2.6

5.8

mmol/l

6.9

7.3

0.65

281

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

599

1.39

2.23

4.3

3.9

56.8

57.6

0.18

599

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

142

1.84

2.23

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

164

1.77

2.22

1.1

1.2

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

187

1.72

2.20

1.5

1.4

titre

30.0

79.3

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

114

1.94

2.20

1.0

6.1

mg/l

82.4

62.2

0.67

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

408

3560

1.17

2.19

5.4

6.9

kpa

5.0

5.1

1.63

386

3392

(3000093) Morphology [Interpretation] in Blood Narrative

273

1.58

2.17

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

2.07

2.16

1.3

1.6

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

108

1.95

2.15

1.0

1.1

ng/l

154.6

479.6

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

3.69

2.15

1.1

—

(3027801) Oxygen [Partial pressure] in Arterial blood

407

3559

1.16

2.13

5.4

6.9

kpa

12.6

12.2

0.78

386

3388

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

189

1.70

2.13

8.8

6.7

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

3.20

2.09

1.5

1.2

—

(3016750) Collection duration of Urine

175

1.72

2.09

2.2

2.0

min

489.6

496.5

0.13

130

(3028626) Oxygen [Partial pressure] in Capillary blood

659

1.36

2.07

2.4

2.9

kpa

8.1

8.0

0.30

609

(3008757) Leukocyte morphology finding [Identifier] in Blood

341

1.50

2.06

4.0

4.3

—

(3044889) 12 lead EKG panel

2189

21090

1.10

2.03

4.4

3.9

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.11

2.02

1.1

—

(3006462) Nitrate [Presence] in Urine

147

1.77

2.02

3.4

4.2

—

(3004775) Volume in Urine collected for unspecified duration

239

1.60

2.01

2.6

2.2

673.1

640.8

0.08

157

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

531

4753

1.14

2.01

1.5

1.4

—

(3005033) Fetal Nuchal fold Thickness US

325

0.52

1.99

1.3

1.4

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

553

1.38

1.98

1.6

1.8

nmol/l

46.8

42.4

0.64

525

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

148

1.76

1.98

1.2

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

126

1.83

1.98

2.0

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

126

1.83

1.98

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

126

1.83

1.98

2.0

1.8

—

(3016038) Potassium [Moles/volume] in Urine

209

1.63

1.97

1.2

1.1

mmol/l

32.6

35.5

0.34

180

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

100

762

1.32

1.95

1.7

1.8

iu/l

2.8

4.6

3.39

264

(3004451) EKG impression Narrative

164

1.71

1.94

1.3

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.55

1.94

1.0

1.1

—

(3047181) Lactate [Moles/volume] in Blood

123

965

1.28

1.93

4.9

6.4

mmol/l

1.4

1.3

0.22

105

850

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

3.75

1.93

1.5

2.1

—

(3023520) Reticulocytes [#/volume] in Blood

306

2641

1.17

1.91

2.7

2.6

e9/l

68.8

70.4

0.34

251

1983

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

316

1.49

1.88

1.7

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

3.19

1.88

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

113

881

1.29

1.87

1.3

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

247

2099

1.19

1.86

1.4

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

159

1.70

1.85

1.8

1.7

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

159

1.70

1.85

1.8

1.7

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

159

1.70

1.85

1.8

1.7

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

159

1.70

1.85

1.8

1.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

400

1.43

1.84

1.8

2.0

pmol/l

188.0

194.3

0.18

378

(3047352) Trisomy 18 risk [Likelihood] in Fetus

327

0.55

1.81

1.3

1.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

658

1.33

1.80

2.1

2.0

u/l

4791.5

3996.5

0.13

267

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

138

1.74

1.79

1.1

—

10.6

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

739

1.31

1.77

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

463

1.39

1.76

1.8

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.09

1.75

1.1

u/ml

0.1

2.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

566

1.35

1.75

1.2

—

255.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.44

1.75

2.0

2.2

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

1.90

1.75

1.1

u/ml

0.1

0.4

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.94

1.74

2.2

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

201

1.60

1.74

1.4

1.3

promille

1.6

1.2

0.67

153

(3043238) Trisomy 21 risk [Likelihood] in Fetus

335

0.56

1.73

1.3

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

170

1.65

1.73

1.1

ratio

1.0

—

(1761482) Bacteria [#/volume] in Urine by Culture

105

821

1.29

1.73

4.8

4.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

125

1.76

1.71

1.0

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

173

1436

1.22

1.70

1.5

1.8

g/l

1.5

0.16

137

1237

(3036670) Protein [Mass/volume] in Synovial fluid

1.91

1.69

1.0

1.2

g/l

43.1

38.6

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

151

1242

1.23

1.63

1.8

2.5

g/l

3.6

3.8

0.97

100

898

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

261

1.50

1.63

1.7

1.5

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

335

2952

1.15

1.63

1.9

2.2

g/l

0.2

1.79

313

2755

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

151

1244

1.22

1.61

1.8

2.5

g/l

7.3

7.4

0.39

104

943

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

151

1244

1.22

1.61

1.8

2.5

—

(3022621) pH of Urine by Test strip

236

2028

1.18

1.60

3.4

3.2

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.95

1.59

1.1

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

121

1.74

1.58

1.1

1.5

umol/l

30.0

0.01

116

(46235355) HIV 1 and 2 tests - Meaningful Use set

450

4052

1.13

1.58

1.5

1.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

239

1.51

1.57

1.6

1.8

umol/l

5.5

8.5

0.53

160

(4211845)

160

1.63

1.55

3.4

4.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

256

1.49

1.55

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

167

1396

1.21

1.55

1.4

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

184

1.58

1.54

2.2

e6/l

551.5

710.5

1.10

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.28

1.53

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

3.34

1.52

1.2

1.1

—

0.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

233

1.51

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

201

1.55

1.51

1.2

u/ml

1.3

1.0

0.12

(3023410) Appearance of Cerebral spinal fluid

266

1.47

1.51

1.8

1.4

—

(4306422)

409

1.38

1.50

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

101

1.79

1.48

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

102

813

1.26

1.48

1.3

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

410

1.37

1.48

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.23

1.46

1.0

1.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1158

1.22

1.46

1.8

2.5

g/l

10.5

10.4

0.08

110

990

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

726

1.27

1.45

2.2

2.3

ug/min

133.3

101.5

0.31

448

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.37

1.45

1.1

—

(3003721) Smooth muscle Ab [Units/volume] in Serum

2.73

1.43

1.0

1.3

—

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

728

1.27

1.43

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

885

0.76

1.41

1.4

1.5

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

205

1.52

1.40

1.2

1.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

140

1164

1.21

1.40

1.8

2.5

g/l

3.0

3.1

0.73

100

920

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.18

1.40

1.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

111

1.72

1.39

2.7

2.1

umol/l

44.1

51.5

0.54

(3042936) Bacteria identified in Isolate by Culture

474

4322

1.11

1.35

1.9

2.0

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

215

1.49

1.35

1.3

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

112

1.70

1.35

2.3

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

1.34

0.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

392

1.36

1.34

1.2

1.1

122.3

117.4

0.50

351

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.15

1.33

1.1

1.0

—

(3025159) Blasts/100 leukocytes in Blood

259

2280

1.15

1.32

4.0

4.1

0.7

0.4

0.19

573

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

283

1.42

1.31

7.3

4.9

u/ml

41.4

87.9

0.75

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.50

1.30

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.36

1.29

1.1

1.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.36

1.29

1.0

1.1

—

(3010503) CD19 cells [#/volume] in Blood

177

1.53

1.28

1.9

2.1

e9/l

0.1

0.4

0.92

170

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

2.78

1.28

1.2

1.1

—

0.1

—

(3021901) Oxygen saturation in Capillary blood

562

1.29

1.27

2.5

2.8

—

(3021440) Promyelocytes/100 leukocytes in Blood

274

2429

1.14

1.27

4.2

0.1

0.2

0.25

679

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

107

876

1.23

1.27

1.7

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.05

1.26

1.1

1.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

294

1.40

1.26

1.3

1.4

e6/l

238826.6

100994.5

0.39

202

(3032773) Endomysium IgG Ab [Titer] in Serum

219

1.47

1.25

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

118

979

1.21

1.23

2.0

2.4

g/l

39.1

37.7

1.85

843

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

155

1.55

1.22

1.3

1.1

—

(4133840)

1.91

1.22

1.2

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

279

1.40

1.22

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

127

1063

1.20

1.22

2.0

2.6

g/l

0.9

1.0

0.06

928

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

674

1.25

1.20

1.2

1.3

miu/ml

179.9

212.8

0.42

301

(3044927) Protein electrophoresis panel - Urine

331

1.36

1.20

1.0

1.2

—

(3017181) Myelocytes/100 leukocytes in Blood

286

2554

1.13

1.19

4.2

4.1

0.9

0.09

734

(3005570) Glucose [Moles/volume] in Urine

323

1.37

1.19

1.8

1.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

577

1.27

1.19

1.4

2.0

nmol/l

0.9

0.8

0.40

471

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.75

1.19

1.3

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.75

1.19

1.3

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

169

0.53

1.18

1.0

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.78

1.16

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

351

1.34

1.15

1.4

2.0

—

3.8

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

352

1.34

1.13

1.1

u/ml

0.3

1.2

1.54

149

(21494755) Public health laboratory ask at order entry panel

178

2044

0.86

1.13

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

662

1.24

1.13

2.2

3.2

u/ml

264.5

827.8

0.74

607

(3006184) Hemoglobin [Mass/volume] in Capillary blood

681

1.24

1.12

2.2

g/l

129.3

127.1

0.31

497

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

200

1.45

1.12

1.5

1.8

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

159

1.51

1.11

1.6

1.8

u/field

2.6

2.1

0.09

110

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

371

1.33

1.11

1.4

1.5

62.5

59.9

0.17

235

(3003888) Timothy IgE Ab [Units/volume] in Serum

363

1.33

1.09

1.1

u/ml

4.0

0.00

181

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

656

1.24

1.09

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

656

1.24

1.09

1.5

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

416

1.30

1.09

1.2

u/ml

5.5

4.7

0.14

175

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.82

1.09

1.2

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

286

1.37

1.08

1.6

1.5

—

(3003338) MCHC [Mass/volume]

2380

24305

0.94

1.07

21.8

19.5

g/l

332.2

331.5

2.94

2368

24104

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

166

0.54

1.07

1.0

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.69

1.07

1.1

1.3

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.71

1.05

1.1

—

(3019977) pH of Arterial blood

170

1.47

1.04

2.8

2.7

7.4

0.05

(3020779) Urea [Moles/volume] in Serum or Plasma

299

2703

1.12

1.04

4.1

7.2

mmol/l

9.4

10.2

1.27

276

2574

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.41

0.99

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.41

0.99

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.41

0.99

1.2

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

321

2923

1.11

0.99

6.2

7.7

g/l

123.6

120.6

1.92

309

2818

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

274

1.35

0.99

1.8

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

274

1.35

0.99

1.8

1.6

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

274

1.35

0.99

1.8

1.6

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

731

1.21

0.96

2.6

3.0

mg/l

1.6

0.10

660

(3052851) Hemolysis interference index of Serum or Plasma

111

944

1.18

0.95

3.5

—

(3000991) Gas panel - Venous blood

275

2491

1.11

0.94

5.9

7.8

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

166

1.45

0.94

2.0

1.3

nmol/l

1.3

1.1

0.34

133

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.22

0.93

1.3

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

356

1.30

0.93

1.5

1.4

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

150

1.47

0.92

1.3

1.2

—

(3042631) Mycobacterium sp identified in Specimen

436

1.27

0.92

3.4

2.8

—

(1617658) Protocol used for examination of sentinel lymph nodes

278

1.33

0.91

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

102

1.57

0.90

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.07

0.89

1.3

1.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.91

0.88

1.4

1.3

—

(3019832) Treponema pallidum Ab [Presence] in Serum

197

1761

1.13

0.87

1.4

1.6

—

(3002179) Metamyelocytes/100 leukocytes in Blood

256

2325

1.11

0.86

4.1

3.9

0.6

0.02

518

(3019150) Specific gravity of Urine by Refractometry

678

6419

1.07

0.85

4.7

4.3

kg/l

1.0

0.13

128

949

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

523

1.23

0.85

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

256

1.33

0.84

1.7

2.2

u/field

6.1

1.9

0.72

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

1.94

0.84

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

1.94

0.84

1.3

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

179

1.40

0.84

1.1

—

(40768446) Kidney Pathology biopsy report

112

0.53

0.83

1.2

1.6

—

(3045788) Cell count panel - Pleural fluid

308

0.71

0.83

1.5

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

171

1.41

0.83

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

172

1.40

0.80

1.1

1.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

374

1.26

0.79

1.1

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

416

3882

1.08

0.79

5.5

6.5

mmol/l

104.8

104.2

1.93

407

3794

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.59

0.78

1.5

1.3

59.1

31.2

—

(3025315) Body weight

0.00

0.77

0.0

4.6

—

(3024928) Oxygen saturation in Venous blood

612

1.20

0.77

2.2

2.7

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

222

0.67

0.77

1.2

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

1.77

0.76

1.2

1.1

—

(3006270) Folate [Moles/volume] in Blood

261

1.31

0.76

1.3

1.2

nmol/l

329.6

365.3

0.40

224

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.76

0.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

112

976

1.15

0.75

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.54

0.75

1.3

1.1

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

392

0.76

0.74

1.3

1.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

560

1.20

0.74

1.8

1.6

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

391

0.77

0.73

1.3

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

390

0.77

0.72

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

390

0.77

0.72

1.3

1.4

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.80

0.72

1.3

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.52

0.72

1.3

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

850

1.16

0.71

1.9

2.0

96.8

91.0

2.29

798

(3011397) Hemoglobin [Presence] in Urine by Test strip

739

7062

1.06

0.71

4.0

3.8

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

229

1.31

0.71

1.1

1.0

u/ml

1.8

0.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

282

1.28

0.71

1.1

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

212

1.32

0.70

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

212

1.32

0.70

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

421

0.78

0.70

1.3

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.51

0.69

2.8

1.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

666

1.18

0.69

1.3

1.5

—

(3000012) Reticulocyte production index

152

1.38

0.69

1.8

1.5

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.53

0.69

2.0

1.5

ug/l

9.4

8.7

0.20

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

1.85

0.68

3.0

2.2

mg/l

1.6

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.85

0.68

1.2

1.5

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.64

0.68

1.3

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

213

1.32

0.68

1.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

374

1.23

0.67

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

107

939

1.14

0.67

2.0

2.5

g/l

0.0

0.29

865

(3017143) Hepatitis C virus Ab [Presence] in Serum

311

2892

1.08

0.67

1.3

1.5

—

(3044007) Cell count panel - Peritoneal fluid

0.55

0.67

2.8

2.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

153

1.37

0.67

5.3

4.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

100

874

1.15

0.67

2.1

2.5

g/l

0.0

0.00

804

(3014133) Dog dander IgE Ab [Units/volume] in Serum

276

1.27

0.66

1.1

u/ml

5.0

2.6

0.26

103

(3008152) Bicarbonate [Moles/volume] in Arterial blood

215

1968

1.10

0.66

6.1

6.8

mmol/l

24.8

24.6

0.30

200

1833

(21494815) CD4 cells/100 lymphocytes in Specimen

223

1.30

0.66

1.8

1.9

32.3

44.9

—

(40758292) HTLV I+II Ab panel - Serum

1.59

0.65

1.1

1.4

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

313

1.25

0.65

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

137

1.39

0.64

1.7

2.5

u/ml

1540.6

1164.5

0.15

137

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.48

0.64

1.1

miu/ml

1530.3

1646.1

0.20

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.73

0.64

1.2

1.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.73

0.64

2.6

3.2

—

(40768800) Prostate Pathology biopsy report

524

0.82

0.63

1.2

—

(3018133) Calcium [Moles/volume] in Urine

1.67

0.61

1.0

1.4

mmol/l

2.3

3.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.67

0.61

1.2

1.0

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.48

0.60

1.0

1.1

97.2

88.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.48

0.60

1.0

1.3

103.0

85.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.60

0.0

1.0

—

(1002224) Polysomnography panel

114

1015

1.13

0.60

1.0

1.1

—

(3011412) CD3 cells [#/volume] in Blood

263

1.26

0.59

1.9

2.1

e9/l

1.8

1.1

1.11

161

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.59

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.59

0.0

1.0

—

(3024316) Viscosity of Plasma

0.00

0.59

0.0

1.5

—

1.8

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

180

1645

1.10

0.59

7.8

9.7

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.53

0.59

1.1

1.2

—

(3044941) Cell count panel - Synovial fluid

501

1.18

0.58

1.5

1.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

455

1.19

0.58

1.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

428

1.19

0.58

1.2

u/ml

1.8

3.5

—

138

(3008295) Osmolality of Serum or Plasma

319

1.23

0.57

1.9

1.4

mosm/kgh2o

280.7

276.2

0.57

245

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.54

0.55

1.1

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

616

1.16

0.55

2.5

2.7

umol/l

34.3

35.8

0.19

513

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

677

6506

1.05

0.54

4.6

4.4

23.2

21.7

1.85

372

3287

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.58

0.54

1.2

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

524

1.17

0.54

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

205

0.73

0.54

1.3

1.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

258

1.24

0.53

1.8

1.6

—

(3039443) Prostate specific Ag panel - Serum or Plasma

405

1.19

0.52

1.6

1.7

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.52

0.52

1.3

—

(3052592) Norovirus Ag [Presence] in Stool

1.43

0.52

1.1

1.4

—

(3033799) Differential panel - Peritoneal fluid

0.62

0.52

2.8

2.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

370

0.81

0.52

1.5

1.6

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

109

1.38

0.50

1.9

1.8

ug/l

50.8

59.0

0.26

104

(3028308) Erythrocytes [#/volume] in Pleural fluid

347

0.81

0.50

1.4

1.5

e6/l

44330.4

79386.3

0.67

202

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.47

0.50

1.1

—

(3000285) Sodium [Moles/volume] in Blood

1.56

0.49

1.3

1.1

—

(3048879) Bone marrow aspiration report

1.40

0.48

2.8

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.45

0.48

2.9

2.8

mg/l

6.6

7.4

0.17

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

181

1.27

0.48

1.0

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

108

976

1.11

0.47

1.6

1.7

mg/l

2.8

3.6

0.55

704

(3018572) Chloride [Moles/volume] in Blood

692

1.13

0.47

5.8

7.3

mmol/l

105.0

0.01

621

(3039000) Anion gap in Blood

692

1.13

0.47

5.8

7.3

mmol/l

11.6

11.1

0.46

621

(43055442) Apixaban [Mass/volume] in Serum or Plasma

1.46

0.46

1.6

1.4

ug/l

93.7

122.2

—

(44790049)

353

0.82

0.46

1.5

1.4

—

(44790047)

353

0.82

0.46

1.5

1.4

—

(44790048)

353

0.82

0.46

1.5

1.4

—

(44806118)

353

0.82

0.46

1.5

1.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.60

0.45

1.0

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

843

0.89

0.45

2.0

1.9

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

394

1.17

0.44

4.7

5.2

umol/l

334.5

360.5

0.63

342

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

866

1.11

0.44

2.1

2.5

g/l

0.0

0.00

803

(3043410) Blood group antigens tested for on Red Blood Cells

1.40

0.44

1.3

1.9

—

(3021788) Differential panel - Synovial fluid

563

1.14

0.44

1.5

—

(3035933) Granulocytes/100 leukocytes in Blood

1.45

0.44

1.0

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

113

1029

1.10

0.44

3.0

3.5

mg/l

33.9

66.0

1.50

837

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

762

1.12

0.44

1.8

1.5

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

754

1.12

0.43

1.6

1.5

pmol/l

117.0

210.7

1.68

739

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.61

0.43

1.0

2.7

u/field

0.4

0.8

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

443

1.15

0.42

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

273

0.80

0.42

1.1

1.2

—

(3047189) Immunofixation for 24 hour Urine

162

0.74

0.42

1.3

1.6

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

276

1.20

0.42

2.4

2.3

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.56

0.42

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

566

1.13

0.42

2.7

2.9

—

(3017569) Oxygen content in Arterial blood

158

1.27

0.41

2.2

2.4

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

315

2994

1.06

0.41

1.6

1.8

1.5

0.32

270

2599

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

491

1.14

0.41

1.1

1.2

u/ml

389.0

276.6

0.68

296

(44806420)

1.36

0.41

2.0

2.5

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.36

0.41

1.2

1.1

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.41

0.0

4.1

—

17.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

217

0.78

0.41

6.2

2.6

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.41

0.0

12.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

1.39

0.40

1.6

1.5

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.40

0.0

5.6

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.40

0.0

2.8

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.40

0.0

1.4

—

23.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

490

4717

1.05

0.39

3.2

3.1

ug/l

0.8

0.05

358

3245

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

102

0.69

0.39

1.3

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

106

0.66

0.39

1.1

2.5

—

25219.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

115

1.31

0.38

1.3

1.9

ug/l

16.1

19.1

0.42

103

(3045142) Bone marrow Pathology biopsy report

363

1.16

0.38

1.2

1.3

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

112

1029

1.09

0.38

3.0

3.5

mg/l

45.0

112.9

0.66

838

(3050129) First trimester maternal screen panel - Serum or Plasma

473

0.87

0.38

1.5

—

(4281824)

355

0.84

0.37

1.0

1.2

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

781

1.10

0.37

2.2

2.3

194.7

195.6

0.03

741

(3014007) Fractional oxyhemoglobin in Arterial blood

206

1941

1.07

0.37

7.0

8.4

94.4

93.9

0.56

206

1935

(40765096) Chromosome analysis panel by Banding

113

0.71

0.37

1.0

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.35

0.37

2.6

3.3

—

(3014891) Appearance of Pleural fluid

1.35

0.37

1.8

1.7

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

202

0.79

0.36

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

259

2462

1.06

0.36

3.4

2.6

ml/min/173m2

63.2

64.1

0.13

104

1013

(3043409) Potassium [Moles/volume] in Arterial blood

103

947

1.09

0.35

3.7

4.0

mmol/l

3.8

3.9

0.98

888

(3005082) Progesterone [Moles/volume] in Serum or Plasma

0.64

0.35

1.4

nmol/l

17.8

29.1

—

(3020650) Glucose [Presence] in Urine

0.64

0.35

1.4

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.63

0.35

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.40

0.35

1.0

2.2

umol/l

22.3

17.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.37

0.34

1.0

1.3

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

358

1.15

0.34

1.0

1.1

u/ml

3.4

2.5

—

144

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.34

0.34

1.3

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

349

1.15

0.33

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

415

1.13

0.33

1.1

u/ml

0.3

1.5

2.00

170

(3023430) Cat dander IgE Ab [Units/volume] in Serum

256

1.17

0.33

1.1

u/ml

3.2

2.7

0.14

(3034426) Prothrombin time (PT)

0.67

0.32

1.5

1.3

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

285

0.84

0.32

2.3

2.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

108

1001

1.08

0.32

3.0

3.4

ratio

2.9

1.4

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.35

0.32

1.1

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.31

0.31

1.1

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

446

1.12

0.31

1.2

1.1

iu/ml

97.5

1336.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

147

1.23

0.30

1.2

1.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.25

0.29

1.3

1.4

ng/l

106.1

104.7

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

613

1.09

0.28

1.5

1.7

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

489

1.11

0.27

1.1

1.2

—

(21491868) Cryoglobulin [Mass/volume] in Serum

119

0.76

0.27

1.3

g/l

—

0.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

490

0.90

0.27

1.6

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

347

1.13

0.26

1.6

2.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.21

0.26

1.1

1.3

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.21

0.26

1.9

3.0

—

(4035726)

274

2848

0.96

0.26

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

779

1.08

0.26

1.5

1.6

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

215

1.16

0.26

1.3

1.5

u/l

12.0

13.5

0.71

206

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

357

1.12

0.26

1.7

1.6

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

141

1.21

0.26

1.2

1.4

pmol/l

39.3

61.5

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.68

0.26

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.68

0.26

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.68

0.26

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.68

0.26

1.0

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

329

1.13

0.26

1.1

u/ml

1.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

446

0.90

0.25

1.7

1.4

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

127

0.79

0.25

1.6

mmol/l

7.6

8.0

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

339

1.12

0.25

1.2

u/l

55.3

59.0

0.23

235

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

743

1.08

0.25

1.8

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

811

1.07

0.25

2.0

2.4

g/l

3.7

3.6

0.27

761

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

287

0.87

0.24

1.4

1.3

—

(21494434) Karyotype in Bone marrow

287

0.87

0.24

1.1

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

255

0.86

0.24

1.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.17

0.24

1.8

1.7

—

(3023419) Bacteria identified in Sputum by Culture

398

1.11

0.24

2.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

222

0.86

0.23

1.1

1.0

ng/l

41.2

45.1

0.26

138

(3027456) Digoxin [Moles/volume] in Serum or Plasma

692

0.92

0.23

2.9

3.3

nmol/l

0.9

0.8

0.48

532

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

256

1.13

0.23

1.1

1.0

—

(40768441) Liver Pathology biopsy report

211

0.85

0.23

1.1

1.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.22

0.22

1.0

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

305

1.12

0.21

1.3

1.4

—

21.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

199

0.85

0.21

1.6

1.9

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.19

0.21

1.0

1.7

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.21

0.0

1.0

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.21

0.0

3.5

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

5.0

—

406.3

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

8.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

220

0.86

0.21

1.1

1.0

ng/l

262.7

316.1

0.78

140

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

220

0.86

0.21

1.1

1.0

ng/l

738.5

710.2

0.11

138

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

1.6

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.2

—

2.4

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

469

1.09

0.21

1.3

—

(3023199) Leukocytes [#/volume] in Pleural fluid

387

0.90

0.20

1.4

1.5

e6/l

3281.5

1709.7

0.73

282

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.00

0.20

0.0

1.2

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.20

0.0

2.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

229

0.87

0.20

1.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.18

0.19

1.0

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.22

0.19

3.1

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.22

0.19

3.1

2.5

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

308

1.10

0.19

5.6

3.7

—

(3051651) Icteric interference index of Serum or Plasma

184

1.14

0.19

3.9

3.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

812

1.06

0.19

1.3

1.2

—

(3037756) Immunofixation for Serum or Plasma

684

0.93

0.19

1.5

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

322

0.90

0.18

1.8

1.7

—

(3020876) Protein [Mass/time] in 24 hour Urine

270

1.11

0.18

1.7

1.9

—

1.5

—

(3002619) Bacteria identified in Specimen by Culture

1.21

0.18

1.3

1.2

—

(3020491) Glucose [Moles/volume] in Blood

223

1.12

0.18

1.8

2.0

mmol/l

6.9

0.01

145

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

744

0.94

0.18

1.7

1.6

—

(3051101) Glucose [Moles/volume] in Cord blood

1.17

0.17

3.9

6.1

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

329

1.10

0.17

1.3

mmol/l

7.5

0.00

243

(3051387) C reactive protein [Mass/volume] in Capillary blood

661

0.94

0.17

3.8

3.5

mg/l

25.8

28.0

0.16

414

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.11

0.17

7.4

7.5

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

201

1946

1.03

0.17

6.9

8.3

1.2

1.4

0.96

201

1934

(3002331) Protein [Mass/volume] in Peritoneal fluid

0.71

0.16

2.2

1.5

g/l

28.7

25.9

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

566

0.94

0.16

1.1

1.6

—

(40757373) Influenza virus identified in Isolate

1.11

0.16

1.1

1.5

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

149

1.14

0.15

1.0

—

(3029075) Extractable nuclear Ab panel - Serum

1.15

0.15

1.2

1.1

—

(3002385) Erythrocyte distribution width [Ratio]

2421

24099

1.01

0.14

20.8

18.2

13.7

13.8

2.29

2380

23532

(3025130) Human papilloma virus identified in Specimen

368

0.92

0.14

1.3

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

138

1428

0.97

0.14

1.5

—

(40768806) Pleura Pathology biopsy report

334

0.93

0.12

1.5

1.6

—

(3017704) Immunofixation for Urine

181

1.11

0.12

1.8

1.6

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

415

1.06

0.11

3.9

6.8

mg/l

12.7

12.3

0.18

384

(3015183) Erythrocyte sedimentation rate

126

0.87

0.11

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

126

0.87

0.11

1.5

2.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

126

0.87

0.11

1.1

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

190

1856

1.03

0.11

1.3

1.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

564

1.05

0.10

3.0

5.2

iu/ml

315.8

603.0

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

341

0.94

0.10

1.4

1.5

nmol/l

0.3

0.12

258

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

135

0.89

0.09

1.0

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

135

0.89

0.09

1.7

nmol/l

3.4

6.5

—

113

(21494814) CD8 cells/100 lymphocytes in Specimen

116

1.12

0.09

1.4

1.8

—

(4268621)

282

1.06

0.09

2.2

2.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.07

0.08

1.8

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

206

0.92

0.08

1.2

1.5

g/l

0.9

1.0

0.64

206

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

119

1160

1.03

0.08

2.1

3.4

u/ml

146.7

3802.6

0.88

977

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

107

1.12

0.08

1.4

1.0

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

479

1.04

0.08

1.3

1.4

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

113

0.88

0.08

1.2

1.1

iu/ml

85.5

184.4

—

113

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

263

1.07

0.08

1.3

1.5

—

(3000034) Microalbumin [Mass/volume] in Urine

267

0.94

0.08

3.5

3.1

mg/l

49.1

34.5

0.18

195

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.78

0.08

3.0

2.4

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.77

0.08

1.2

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

342

1.05

0.08

3.8

3.6

—

(3020891) Body temperature

130

1271

1.02

0.08

4.7

4.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

166

1.08

0.07

1.8

2.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

184

0.92

0.07

2.0

1.5

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

284

1.06

0.07

1.5

1.4

30.4

31.2

0.05

173

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

153

0.91

0.07

2.4

3.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

531

1.04

0.07

1.2

1.4

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.02

0.07

1.1

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

183

0.93

0.06

2.0

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

750

0.97

0.06

1.1

1.3

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

109

1.10

0.06

1.2

1.0

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

207

1.06

0.06

1.2

1.5

u/l

2.8

7.0

—

100

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

213

0.94

0.06

2.3

1.5

ug/l

3.3

4.3

0.29

180

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

435

1.03

0.05

1.8

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

161

0.93

0.05

1.7

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

161

0.93

0.05

1.7

1.5

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

110

1.09

0.05

2.2

2.5

umol/l

213.8

140.3

—

(40760888) Immunoglobulin light chains.free panel - Serum

777

0.98

0.05

3.6

—

(3003694) ABO and Rh group [Type] in Blood

784

7875

0.99

0.04

1.4

—

(40768795) Lymph node Pathology biopsy report

319

1.03

0.03

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

552

0.98

0.03

1.6

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

104

1054

0.99

0.03

3.1

3.0

u/ml

0.4

0.73

609

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

209

0.96

0.03

1.9

1.5

—

(3016228) CD19 cells/100 cells in Blood

122

1.07

0.02

1.4

1.8

6.8

9.0

0.54

116

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

213

2145

0.99

0.02

1.8

—

(3012441) Differential panel - Pleural fluid

319

0.97

0.02

1.3

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

129

1301

0.99

0.02

1.5

1.7

—

(3024263) Appearance of Synovial fluid

167

0.96

0.01

1.6

1.7

—

(3035880) pH of Pleural fluid

187

0.96

0.01

1.4

1.3

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

104

1.06

0.01

1.2

1.3

—

(3036603) Volume of Urine

214

1.03

0.00

1.6

1.4

2019.6

1873.1

—

(3011648) Oxygen content in Venous blood

234

1.03

0.00

2.3

1.8

10.9

0.01

234

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

466

0.99

0.00

1.1

1.4

u/ml

133.0

121.6

0.12

(3037556) Urate [Mass/volume] in Serum or Plasma

1.02

0.00

1.1

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

105

1.05

0.00

1.3

1.1

—

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

258

1.01

0.00

1.4

1.9

mg/l

4.0

4.4

0.16

250

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

378

1.01

0.00

1.1

g/l

1.3

1.5

5.10

342

(40768793) Breast Pathology biopsy report

798

1.00

0.00

1.4

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

151

0.99

0.00

1.1

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

352

3523

1.00

0.00

1.4

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

403

0.99

0.00

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

427

1.01

0.00

1.6

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

223

0.99

0.00

1.3

u/l

15.7

11.2

0.50

207

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.4

—

153.9

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

430

1.00

0.00

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.1

—

(3034614) HLA Ag [Interpretation]

0.00

0.0

1.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.97

0.00

2.0

1.7

—

(3022689) Creatine [Moles/volume] in Urine

0.89

0.00

2.0

1.5

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.00

0.00

2.2

2.4

199.4

174.9

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

0.95

0.00

1.2

1.5

—

(21493866) Erythrocytes [#/volume] in Peritoneal dialysis fluid by Automated count

0.00

0.0

8.0

—

74.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.0

2.2

—

4.4

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

100

1.00

0.00

1.2

1.6

8.0

3.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.88

0.00

1.4

1.8

—

73.7

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.0

2.1

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.88

0.00

1.8

1.1

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.1

—

1.3

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

0.95

0.00

1.3

1.5

18.0

23.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint H8_PERIPHVERTIGO and mortality.

Females

Parameter	HR [95% CI]	p-value
H8_PERIPHVERTIGO	0.894 [0.82, 0.97]	0.011
Birth year	0.99 [0.98, 1.0]	0.021

During the follow-up period (1.1.1998 — 31.12.2019), 2271 out of 12753 females with H8_PERIPHVERTIGO died.

Males

Parameter	HR [95% CI]	p-value
H8_PERIPHVERTIGO	0.862 [0.78, 0.95]	0.003
Birth year	0.985 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 1428 out of 7125 males with H8_PERIPHVERTIGO died.

Mortality risk

Mortality risk for people of age

years, who have H8_PERIPHVERTIGO.

N-year risk	Females	Males
1	0.056%	0.167%
5	0.442%	1.004%
10	1.156%	2.399%
15	2.051%	4.41%
20	3.659%	7.397%

Relationships between endpoints

↥

Index endpoint: H8_PERIPHVERTIGO – Other peripheral vertigo

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other peripheral vertigo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints